-
公开(公告)号:EP3322420A1
公开(公告)日:2018-05-23
申请号:EP16824927.4
申请日:2016-07-08
发明人: SHAO, Pengcheng Patrick , KATIPALLY, Revathi Reddy , VACHAL, Petr , THATAI, Jayanth Thiruvellore , SARKAR, Sujit Kumar
IPC分类号: A61K31/4439 , C07D498/04
CPC分类号: C07D513/04 , A61K31/407 , A61K31/429 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/519 , A61K31/714 , A61K45/06 , C07D487/04 , C07D498/04 , A61K2300/00
摘要: The invention provides compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, wherein D1, D2, D3, X, Y, A1, A2, R1, R5 and the subscript a are as described herein. The compounds are CETP inhibitors and are useful for raising FIDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:
-
公开(公告)号:EP3052099B1
公开(公告)日:2019-08-21
申请号:EP14850990.4
申请日:2014-09-29
发明人: BARR, Kenneth Jay , SCOTT, Mark E. , THOMPSON, Christopher F. , ANTHONY, Neville , CAMMARANO, Carolyn Michelle , BAKSHI, Raman Kumar , MOHANTY, Subhendu Kumar , KORAPALA, Chandra Sekhar , LATTHE, Prashant R. , KAMBAM, Vyjayanthi N. , SARKAR, Sujit Kumar , THATAI, Jayanth Thiruvellore
IPC分类号: A61K31/435 , A61K31/4439
-
公开(公告)号:EP3052099A1
公开(公告)日:2016-08-10
申请号:EP14850990.4
申请日:2014-09-29
发明人: BARR, Kenneth Jay , SCOTT, Mark E. , THOMPSON, Christopher F. , ANTHONY, Neville , CAMMARANO, Carolyn Michelle , BAKSHI, Raman Kumar , MOHANTY, Subhendu Kumar , KORAPALA, Chandra Sekhar , LATTHE, Prashant R. , KAMBAM, Vyjayanthi N. , SARKAR, Sujit Kumar , THATAI, Jayanth Thiruvellore
IPC分类号: A61K31/435 , A61K31/4439
CPC分类号: A61K31/4439 , A61K31/437 , A61K31/444 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/517 , A61K31/519 , A61K45/06 , C07B2200/07 , C07C53/06 , C07C53/18 , C07D207/08 , C07D207/09 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/14 , C07D471/04 , C07D495/04 , A61K2300/00
摘要: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
摘要翻译: 本发明提供式(I)化合物,其药物组合物及其用于治疗或预防β3肾上腺素受体激活介导的疾病的方法。
-
-